Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Debt Ratio: 2011-2025

Historic Debt Ratio for Ani Pharmaceuticals (ANIP) over the last 10 years, with Sep 2025 value amounting to 0.22.

  • Ani Pharmaceuticals' Debt Ratio fell 10.62% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 10.62%. This contributed to the annual value of 0.25 for FY2024, which is 24.52% down from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Debt Ratio is 0.22, which was down 5.17% from 0.23 recorded in Q2 2025.
  • Ani Pharmaceuticals' Debt Ratio's 5-year high stood at 0.43 during Q3 2021, with a 5-year trough of 0.22 in Q3 2025.
  • For the 3-year period, Ani Pharmaceuticals' Debt Ratio averaged around 0.30, with its median value being 0.31 (2024).
  • Its Debt Ratio has fluctuated over the past 5 years, first increased by 5.67% in 2021, then decreased by 28.39% in 2024.
  • Over the past 5 years, Ani Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.37 in 2021, then grew by 1.21% to 0.38 in 2022, then decreased by 12.86% to 0.33 in 2023, then decreased by 24.52% to 0.25 in 2024, then decreased by 10.62% to 0.22 in 2025.
  • Its last three reported values are 0.22 in Q3 2025, 0.23 for Q2 2025, and 0.24 during Q1 2025.